Athena Athena

X

Digital content for Asieris Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Asieris Pharmaceuticals
China Flag
Country
Country
China
Address
Address
12th Floor, Building 56, Jinling Capital, No, 1000, Jinhai Road, Pudong New Area, Shanghai
Telephone
Telephone
+ (86) 021-6858-5280
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/breakthrough-in-treatment-of-cervical-high-grade-squamous-intraepithelial-lesion-release-of-positive-results-from-multicenter-phase-iii-global-clinical-study-302092249.html

PR NEWSWIRE
18 Mar 2024

https://www.prnewswire.com/news-releases/photocure-partner-asieris-announces-positive-international-phase-iii-clinical-trial-results-for-cevira-and-data-presentations-at-the-2024-eurogin-congress-and-sgo-annual-meeting-302091288.html

PR NEWSWIRE
18 Mar 2024

https://www.prnewswire.com/news-releases/asieris-releases-phase-iii-clinical-study-and-real-world-research-data-for-apl-1706-a-bladder-cancer-diagnosis-and-management-drug-at-the-2024-asco-gu-302046514.html

PR NEWSWIRE
29 Jan 2024

https://www.prnewswire.com/news-releases/asieris-will-present-for-the-first-time-interim-analysis-data-of-oral-apl-1202-in-combination-with-pd-1-inhibitor-tislelizumab-for-neoadjuvant-treatment-of-muscle-invasive-bladder-cancer-at-2024-asco-gu-302044439.html

PR NEWSWIRE
25 Jan 2024

https://www.prnewswire.com/news-releases/enhancing-leadership-in-gynecology-asieris-pharmaceuticals-appoints-sophia-cao-to-lead-the-newly-established-womens-health-business-unit-accelerating-strategic-expansion-302029233.html

PR NEWSWIRE
08 Jan 2024

https://www.prnewswire.com/news-releases/apl-2301-a-compound-developed-by-asieris-for-the-treatment-of-acinetobacter-baumannii-infection-was-approved-for-phase-i-clinical-trials-in-australia-302022122.html

PR NEWSWIRE
24 Dec 2023

https://www.prnewswire.com/news-releases/asieris-unveiled-results-of-its-phase-iii-clinical-study-for-apl-1706-an-imaging-drug-for-diagnosis-or-surgery-of-bladder-cancer-at-the-siu-2023-congress-301954806.html

PR NEWSWIRE
12 Oct 2023

https://www.prnewswire.com/news-releases/asieris-new-drug-apl-1401-completes-first-administration-in-patient-with-moderately-to-severely-active-uc-301927542.html

PR NEWSWIRE
14 Sep 2023

https://www.prnewswire.com/news-releases/asieris-obtained-ind-approval-from-nmpa-for-apl-1401-a-drug-for-the-treatment-of-moderately-to-severely-active-ulcerative-colitis-301913403.html

PR NEWSWIRE
30 Aug 2023

https://www.prnewswire.com/news-releases/asieris-pharmaceuticals-unveils-2023-semi-annual-report-demonstrating-initial-success-of-specialty-pharma-strategy-and-multi-product-synergistic-commercialization-301906832.html

PR NEWSWIRE
22 Aug 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY